Genoskin
Ex vivo human skin models, mast cells and research services for pharmaceutical, biotech, cosmetics and medical-device developers
Highlights
- New on EvolcAdded 2026-10-30
About Genoskin
Genoskin develops living, immunocompetent ex vivo human skin models and primary human mast cells, and provides custom non-clinical studies using these models. Services cover drug and vaccine development, toxicity and injection-site reaction testing, topical products, cosmetics and medical devices.
Customers include pharmaceutical and biotech companies, cosmetics and consumer-goods businesses, medical-device manufacturers, and academic researchers. It sells research-ready models through an e-shop and earns service revenue from custom study design and execution.
Founded in 2011, Genoskin is headquartered in Toulouse, France, with operations in France and the United States. Its main French facility has been ISO 9001:2015 certified since 2017.
Product: Ex vivo human skin models, primary human mast cells, and custom non-clinical research services.
Jobs at Genoskin
Leadership
- Pascal Descargues · Founder, CEOSource: company website
- Frederick Roques · Chief Financial OfficerSource: company website
- Anna Falkovsky · Vice President of SalesSource: company website
- Lorna Santos · Vice President of Research & Product DevelopmentSource: company website
More biotech & pharma companies
Genoway
Preclinical mouse, rat and cell line models with custom model design for pharma and academic researchersNew on EvolcGensensor
Automated bioprocess sampling robot and AI analytics for biologics makers in biomedicine, agri-food and cosmeticsYoung companyNew on EvolcGensight Biologics
Clinical-stage gene therapies for inherited eye diseases such as LHON and retinitis pigmentosa, developed in ParisNew on EvolcGreencell
Microbial biotechnology products for agriculture, water treatment, waste management, and health and nutrition businessesNew on EvolcGreenpharma
Supplies natural active ingredients, compound libraries and contract R&D to cosmetic, pharma and agrifood companiesNew on EvolcHemarina
Develops marine-worm-derived oxygen carriers for therapeutic use, including organ preservation and reconstructive surgeryNew on Evolc
Website technologies
Older, unverified list. Detection dates and supporting evidence are not yet available.
- Apache
- Complianz
- Google Tag Manager
- HubSpot
- Matomo
- PHP
- WooCommerce
- WordPress
- jQuery
